# Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension

> **NCT01279083** · PHASE1,PHASE2 · COMPLETED · sponsor: **Santen Inc.** · enrollment: 147 (actual)

## Conditions studied

- Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** DE-112
- **DRUG:** DE-112
- **DRUG:** DE-112
- **DRUG:** DE-112
- **DRUG:** DE-112 Vehicle Solution
- **DRUG:** Timolol Maleate Solution

## Key facts

- **NCT ID:** NCT01279083
- **Lead sponsor:** Santen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-11
- **Final completion:** 2012-02
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2012-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01279083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01279083, "Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01279083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*